155 related articles for article (PubMed ID: 31470788)
21. Pseudoginsenoside-F11 alleviates cognitive deficits and Alzheimer's disease-type pathologies in SAMP8 mice.
Zhang Z; Yang J; Liu C; Xie J; Qiu S; Yang X; Wu C
Pharmacol Res; 2019 Jan; 139():512-523. PubMed ID: 30394318
[TBL] [Abstract][Full Text] [Related]
22. Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A.
Zhou XW; Gustafsson JA; Tanila H; Bjorkdahl C; Liu R; Winblad B; Pei JJ
Neurobiol Dis; 2008 Sep; 31(3):386-94. PubMed ID: 18586097
[TBL] [Abstract][Full Text] [Related]
23. The blockage of the Nogo/NgR signal pathway in microglia alleviates the formation of Aβ plaques and tau phosphorylation in APP/PS1 transgenic mice.
Fang Y; Yao L; Li C; Wang J; Wang J; Chen S; Zhou XF; Liao H
J Neuroinflammation; 2016 Mar; 13(1):56. PubMed ID: 26939570
[TBL] [Abstract][Full Text] [Related]
24. Antihelminthic drug niclosamide inhibits CIP2A and reactivates tumor suppressor protein phosphatase 2A in non-small cell lung cancer cells.
Kim MO; Choe MH; Yoon YN; Ahn J; Yoo M; Jung KY; An S; Hwang SG; Oh JS; Kim JS
Biochem Pharmacol; 2017 Nov; 144():78-89. PubMed ID: 28813646
[TBL] [Abstract][Full Text] [Related]
25. Exploring Alzheimer molecular pathology in Down's syndrome cerebrospinal fluid.
Portelius E; Soininen H; Andreasson U; Zetterberg H; Persson R; Karlsson G; Blennow K; Herukka SK; Mattsson N
Neurodegener Dis; 2014; 14(2):98-106. PubMed ID: 24992945
[TBL] [Abstract][Full Text] [Related]
26. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease.
Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX
Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414
[TBL] [Abstract][Full Text] [Related]
27. Chronic Cigarette Smoke Exposure Subdues PP2A Activity by Enhancing Expression of the Oncogene CIP2A.
Nath S; Ohlmeyer M; Salathe MA; Poon J; Baumlin N; Foronjy RF; Geraghty P
Am J Respir Cell Mol Biol; 2018 Dec; 59(6):695-705. PubMed ID: 30011381
[TBL] [Abstract][Full Text] [Related]
28. PTPA activates protein phosphatase-2A through reducing its phosphorylation at tyrosine-307 with upregulation of protein tyrosine phosphatase 1B.
Luo Y; Nie YJ; Shi HR; Ni ZF; Wang Q; Wang JZ; Liu GP
Biochim Biophys Acta; 2013 May; 1833(5):1235-43. PubMed ID: 23428800
[TBL] [Abstract][Full Text] [Related]
29. The secreted APP ectodomain sAPPα, but not sAPPβ, protects neurons against Aβ oligomer-induced dendritic spine loss and increased tau phosphorylation.
Tackenberg C; Nitsch RM
Mol Brain; 2019 Mar; 12(1):27. PubMed ID: 30922360
[TBL] [Abstract][Full Text] [Related]
30. Direct Activation of Protein Phosphatase 2A (PP2A) by Tricyclic Sulfonamides Ameliorates Alzheimer's Disease Pathogenesis in Cell and Animal Models.
Wei H; Zhang HL; Wang XC; Xie JZ; An DD; Wan L; Wang JZ; Zeng Y; Shu XJ; Westermarck J; Lu YM; Ohlmeyer M; Liu R
Neurotherapeutics; 2020 Jul; 17(3):1087-1103. PubMed ID: 32096091
[TBL] [Abstract][Full Text] [Related]
31. Notopterygium incisum extract (NRE) rescues cognitive deficits in APP/PS1 Alzhneimer's disease mice by attenuating amyloid-beta, tau, and neuroinflammation pathology.
Jiang XW; Liu WW; Wu YT; Wu Q; Lu HY; Xu ZH; Gao HY; Zhao QC
J Ethnopharmacol; 2020 Mar; 249():112433. PubMed ID: 31783135
[TBL] [Abstract][Full Text] [Related]
32. Cucurbitacin B induces inhibitory effects via the CIP2A/PP2A/C-KIT signaling axis in t(8;21) acute myeloid leukemia.
Ma W; Xiang Y; Yang R; Zhang T; Xu J; Wu Y; Liu X; Xiang K; Zhao H; Liu Y; Si Y
J Pharmacol Sci; 2019 Apr; 139(4):304-310. PubMed ID: 30852180
[TBL] [Abstract][Full Text] [Related]
33. Soluble amyloid precursor protein alpha inhibits tau phosphorylation through modulation of GSK3β signaling pathway.
Deng J; Habib A; Obregon DF; Barger SW; Giunta B; Wang YJ; Hou H; Sawmiller D; Tan J
J Neurochem; 2015 Nov; 135(3):630-7. PubMed ID: 26342176
[TBL] [Abstract][Full Text] [Related]
34. Oncoprotein CIP2A is stabilized via interaction with tumor suppressor PP2A/B56.
Wang J; Okkeri J; Pavic K; Wang Z; Kauko O; Halonen T; Sarek G; Ojala PM; Rao Z; Xu W; Westermarck J
EMBO Rep; 2017 Mar; 18(3):437-450. PubMed ID: 28174209
[TBL] [Abstract][Full Text] [Related]
35. Hyperphosphorylated tau and paired helical filament-like structures in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes.
Kurt MA; Davies DC; Kidd M; Duff K; Howlett DR
Neurobiol Dis; 2003 Oct; 14(1):89-97. PubMed ID: 13678670
[TBL] [Abstract][Full Text] [Related]
36. The Isoquinoline Alkaloid Dauricine Targets Multiple Molecular Pathways to Ameliorate Alzheimer-Like Pathological Changes
Liu P; Chen X; Zhou H; Wang L; Zhang Z; Ren X; Zhu F; Guo Y; Huang X; Liu J; Spencer PS; Yang X
Oxid Med Cell Longev; 2018; 2018():2025914. PubMed ID: 30057671
[TBL] [Abstract][Full Text] [Related]
37. CIP2A mediates erlotinib-induced apoptosis in non-small cell lung cancer cells without EGFR mutation.
Wang CY; Chao TT; Chang FY; Chen YL; Tsai YT; Lin HI; Huang YC; Shiau CW; Yu CJ; Chen KF
Lung Cancer; 2014 Aug; 85(2):152-60. PubMed ID: 24954871
[TBL] [Abstract][Full Text] [Related]
38. Suppression of cyclin-dependent kinase 5 activation by amyloid precursor protein: a novel excitoprotective mechanism involving modulation of tau phosphorylation.
Han P; Dou F; Li F; Zhang X; Zhang YW; Zheng H; Lipton SA; Xu H; Liao FF
J Neurosci; 2005 Dec; 25(50):11542-52. PubMed ID: 16354912
[TBL] [Abstract][Full Text] [Related]
39. ChK1 activation induces reactive astrogliosis through CIP2A/PP2A/STAT3 pathway in Alzheimer's disease.
Zhou Y; Liu X; Ma S; Zhang N; Yang D; Wang L; Ye S; Zhang Q; Ruan J; Ma J; Wang S; Jiang N; Zhao Z; Zhao S; Zheng C; Fan X; Gong Y; Abdoul Razak MY; Hu W; Pan J; Wang X; Fan J; Li J; Liu R; Shentu Y
FASEB J; 2022 Mar; 36(3):e22209. PubMed ID: 35195302
[TBL] [Abstract][Full Text] [Related]
40. Potassium 2-(1-hydroxypentyl)-benzoate improves memory deficits and attenuates amyloid and τ pathologies in a mouse model of Alzheimer's disease.
Peng Y; Hu Y; Xu S; Rong X; Li J; Li P; Wang L; Yang J; Wang X
J Pharmacol Exp Ther; 2014 Aug; 350(2):361-74. PubMed ID: 24893984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]